文献速递免疫规划传染病防控与疫情报告职业卫生

2020/21季流感疫苗对意大利医护人员SARS-CoV-2感染的影响:一项队列研究

Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers.
PubMed 文献 · Vaccine · 2022-02-07

研究纳入2561名医护人员,回顾性随访至COVID-19疫苗接种开始,2020/21季流感疫苗接种率为35.6%,期间发生290例新发SARS-CoV-2感染。接种者发病率1.62/1000人日,未接种者3.91/1000人日,调整后非比例风险比为0.37(95%CI 0.22-0.62),E值提示未测量混杂不太可能解释该关联。

要点

  • 接种2020/21季流感疫苗的医护人员SARS-CoV-2感染风险较低。
  • 接种者发病率1.62/1000人日,未接种者3.91/1000人日。
  • 调整后非比例风险比0.37(95%CI 0.22-0.62)。

核心结论

  • 在医护人员中观察到接种2020/21季流感疫苗者SARS-CoV-2感染风险较低。

研究设计与样本

  • 观察性研究,对一家约5000名员工的大型三级急性护理大学医院所属医护人员进行回顾性随访,直至COVID-19疫苗接种活动开始。
  • 最终队列包含2561名至少接受1次RT-PCR检测的医护人员,累计观察94445人日。
  • 暴露变量为2020/21季流感疫苗接种,研究结局为经RT-PCR确认的新发SARS-CoV-2感染,采用多变量Cox回归分析关联。

主要发现

  • 2020/21季流感疫苗接种率为35.6%。
  • 研究期间共发生290例新发SARS-CoV-2感染。
  • 接种者新发SARS-CoV-2发病率1.62(95%CI 1.22-2.10)/1000人日,未接种者3.91(95%CI 3.43-4.45)/1000人日。
  • 调整后非比例风险比为0.37(95%CI 0.22-0.62)。
  • E值提示未测量混杂不太可能解释该关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Healthcare workers (HCWs) are a priority group for seasonal influenza vaccination (SIV). The 2020/21 SIV campaign was conducted during the second wave of the COVID-19 pandemic. Vaccines, including SIV, may exert non-specific protective effects on other infectious diseases which may be ascribable to the concept of trained immunity. The aim of this study was to explore the association between 2020/21 SIV and SARS-CoV-2 positivity in a cohort of Italian HCWs. METHODS: In this observational study, a cohort of HCWs employed by a large (ca 5000 employees) referral tertiary acute-care university hospital was followed up retrospectively until the start of the COVID-19 vaccination campaign. The independent variable of interest was the 2020/21 SIV uptake. Both egg-based and cell culture-derived quadrivalent SIVs were available. The study outcome was the incidence of new SARS-CoV-2 infections, as determined by RT-PCR. Multivariable Cox regression was applied in order to discern the association of interest. RESULTS: The final cohort consisted of 2561 HCWs who underwent ≥1 RT-PCR test and accounted for a total of 94,445 person-days of observation. SIV uptake was 35.6%. During the study period, a total of 290 new SARS-CoV-2 infections occurred. The incidence of new SARS-CoV-2 was 1.62 (95% CI: 1.22-2.10) and 3.91 (95% CI: 3.43-4.45) per 1000 person-days in vaccinated and non-vaccinated HCWs, respectively, with an adjusted non-proportional hazard ratio of 0.37 (95% CI: 0.22-0.62). E-values suggested that unmeasured confounding was unlikely to explain the association. CONCLUSIONS: A lower risk of SARS-CoV-2 infection was observed among SIV recipients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Domnich A, Orsi A, Sticchi L, et al. Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers. Vaccine. 2022. PMID: 35153098. doi:10.1016/j.vaccine.2022.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。